Sign In
Buy JAGX
$2.92
-0.300 (-9.32%)
At Close: Jun 03, 2026
Jaguar Health shares soar 40% in heavy volume, on track for 18-month high
12:52pm, Tuesday, 05'th Jan 2021
Shares of Jaguar Health Inc., a developer of plant-based medicines for people and animals, soared more than 40% on Tuesday in heavy volume, extending their recent strong gains and putting the stock on
JAGX Stock: 12 Things to Know About Fast-Moving Jaguar Health
08:44am, Tuesday, 05'th Jan 2021
JAGX shares are once again on the move this week. Here's what you should know about the maker of the antidiarrheal treatment Mytesi.
JAGX Stock: Why Jaguar Health Shares Are Surging 150% Today
02:42pm, Wednesday, 23'rd Dec 2020
JAGX stock is up on news that Jaguar Health just signed a royalty deal that will allow the company to pursue new FDA approvals. The post JAGX Stock: Why Jaguar Health Shares Are Surging 150% Today app
Why Cellectar, Jaguar Health And More Are Moving Today
11:33am, Wednesday, 23'rd Dec 2020
Cellectar Biosciences (NASDAQ: CLRB) shares are trading lower on Wednesday after the company priced a $24.5 million offering at $1.35 per share. Cellectar Biosciences Inc is a clinical-stage biopharma
No royalty payments due for 18-24 months Proceeds will be allocated to support regulatory activities associated with the Company's development pipeline, including funding the recently initiated pivota
JAGX Stock Price Increases Over 50%: Why It Happened
11:11am, Tuesday, 01'st Dec 2020
The stock price of Jaguar Health, Inc. (NASDAQ:JAGX) is trading at more than 50% today. This is why it happened.
Jaguar Health: 10 Things for JAGX Stock Investors to Know About the Pharmaceutical Company
10:41am, Tuesday, 01'st Dec 2020
Jaguar Health (JAGX) is on the move Tuesday as shares of JAGX stock continue to rise and InvestorPlace has what investors need to know. The post Jaguar Health: 10 Things for JAGX Stock Investors to Kn
Why Jaguar Health And OncoCyte Are Trading Higher Today
03:27pm, Monday, 30'th Nov 2020
Jaguar Health (NASDAQ: JAGX) shares are trading higher on Monday after the company announced its plans to develop and commercialize its Crofelemer. Jaguar Health is a commercial-stage pharmaceuticals
Jaguar Health, Inc. (JAGX) CEO Lisa Conte on Q3 2020 Results - Earnings Call Transcript
02:15pm, Monday, 16'th Nov 2020
Jaguar Health, Inc. (JAGX) CEO Lisa Conte on Q3 2020 Results - Earnings Call Transcript
Jaguar Health Provides Updates on Investigator-Initiated Trials of Crofelemer (Mytesi)
12:30pm, Wednesday, 19'th Aug 2020
Company shares updates on investigator-initiated trials of crofelemer (Mytesi®), a novel FDA-approved plant-based oral prescription medicineSAN FRANCISCO, CA / ACCESSWIRE / August 19, 2020 / Jaguar H
Jaguar Health Submits Final Regulatory Filing for Approval of Canalevia (Crofelemer) to Treat Chemotherapy-induced Diarrhea in Dogs
12:30pm, Tuesday, 18'th Aug 2020
Canalevia would be first and only FDA-approved plant-based medicine for the more than 50,000 dogs that suffer from diarrhea during chemotherapySAN FRANCISCO, CA / ACCESSWIRE / August 18, 2020 / Jaguar
SAN FRANCISCO, CA / ACCESSWIRE / August 14, 2020 / Jaguar Health, Inc.
Jaguar Health, Inc. Reports 2020 Second Quarter Financial Results
12:00pm, Thursday, 13'th Aug 2020
Q2 2020 Mytesi net sales and gross sales were approximately $3.
Jaguar Health to Host Investor Call August 13th at 8:30 a.m. Eastern Regarding Q2 2020 Financials and Business Updates
12:30pm, Tuesday, 11'th Aug 2020
Company Plans to File Q2 2020 10-Q on August 13, 2020Save the Date: Company to host virtual disease awareness event on October 20, 2020 focused on cancer therapy-related diarrheaSAN FRANCISCO, CA / AC
A significant proportion of patients undergoing cancer therapy experience diarrhea SAN FRANCISCO, CA / ACCESSWIRE / August 6, 2020 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "
